1. Barnard L (1986) Reduction of pituitary tumor size in acromegaly treated with a soma-tostatin analogue (SMS 201–995). 68th Meeting of Endocrine Society, June 25–27, Anaheim (abstract 983)
2. Belforte L, Camanni F, Chiodini PG, Liuzzi A, Massara F, Molinatti GM, Muller EE, Silvestrini F (1977) Long-term treatment with 2Br-alpha ergocryptine in acromegaly. Acta Endocrinol (Copenh) 85: 235–241
3. Besser GM, Wass JAH (1984) The medical treatment of acromegaly. In: Black PL, Zervas NT, Ridgway EC, Martin JB (eds) Secretory Tumors of the Pituitary Gland. Raven, New York, pp 155–168
4. Besser GM, Wass JAH, Grossman A, Moult PJA, Boulox P (1983) Hormonal and clinical aspects of dopamine agonists. In: Calne DB, Horowski H, McDonald JM, Wuttke W (eds) Lisuride and Other Dopamine Agonists. Raven, New York, pp 239–254
5. Ch’ng LJC, Sandier LM, Kraenzli ME, Burrin JM, Joplin JF, Bloom SR (1985) Long-term treatment of acromegaly with a long-acting analog of somatostatin. Br Med J
290: 284–287